Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding
Despite great progress in the field, chronic Pseudomonas aeruginosa (Pa) infections remain a major cause of morbidity and mortality in patients with cystic fibrosis, necessitating treatment with inhaled antibiotics. Pf phage is a filamentous bacteriophage produced by Pa that has been reported to act as a structural element in Pa biofilms. Pf presence has been associated with resistance to antibiotics and poor outcomes in cystic fibrosis, though the underlying mechanisms are unclear. Here, we have investigated how Pf phages and sputum biopolymers impede antibiotic diffusion using human sputum samples and fluorescent recovery after photobleaching. We demonstrate that tobramycin interacts with Pf phages and sputum polymers through electrostatic interactions. We also developed a set of mathematical models to analyze the complex observations. Our analysis suggests that Pf phages in sputum reduce the diffusion of charged antibiotics due to a greater binding constant associated with organized liquid crystalline structures formed between Pf phages and sputum polymers. This study provides insights into antibiotic tolerance mechanisms in chronic Pa infections and may offer potential strategies for novel therapeutic approaches.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
bioRxiv : the preprint server for biology - (2024) vom: 10. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Qingquan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 22.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1101/2024.03.10.584330 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369863127 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369863127 | ||
| 003 | DE-627 | ||
| 005 | 20240323001205.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240318s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2024.03.10.584330 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM369863127 | ||
| 035 | |a (NLM)38496625 | ||
| 035 | |a (PII)2024.03.10.584330 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Qingquan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Despite great progress in the field, chronic Pseudomonas aeruginosa (Pa) infections remain a major cause of morbidity and mortality in patients with cystic fibrosis, necessitating treatment with inhaled antibiotics. Pf phage is a filamentous bacteriophage produced by Pa that has been reported to act as a structural element in Pa biofilms. Pf presence has been associated with resistance to antibiotics and poor outcomes in cystic fibrosis, though the underlying mechanisms are unclear. Here, we have investigated how Pf phages and sputum biopolymers impede antibiotic diffusion using human sputum samples and fluorescent recovery after photobleaching. We demonstrate that tobramycin interacts with Pf phages and sputum polymers through electrostatic interactions. We also developed a set of mathematical models to analyze the complex observations. Our analysis suggests that Pf phages in sputum reduce the diffusion of charged antibiotics due to a greater binding constant associated with organized liquid crystalline structures formed between Pf phages and sputum polymers. This study provides insights into antibiotic tolerance mechanisms in chronic Pa infections and may offer potential strategies for novel therapeutic approaches | ||
| 650 | 4 | |a Preprint | |
| 700 | 1 | |a Cai, Pam |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Tony Hong Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Burgener, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Kratochvil, Michael J |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Aditi |e verfasserin |4 aut | |
| 700 | 1 | |a Hargil, Aviv |e verfasserin |4 aut | |
| 700 | 1 | |a Secor, Patrick R |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Josefine Eilsø |e verfasserin |4 aut | |
| 700 | 1 | |a Barron, Annelise E |e verfasserin |4 aut | |
| 700 | 1 | |a Milla, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Heilshorn, Sarah C |e verfasserin |4 aut | |
| 700 | 1 | |a Spakowitz, Andy |e verfasserin |4 aut | |
| 700 | 1 | |a Bollyky, Paul L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv : the preprint server for biology |d 2020 |g (2024) vom: 10. März |w (DE-627)NLM31090014X |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:10 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.03.10.584330 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 10 |c 03 | ||